MedDataX Logo

Looking for Asymptomatic Mpox in a Population at High Risk

NCT ID: NCT06353737

Last Updated: 2024-04-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

450 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-04-01

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Mpox is caused by a virus that can be spread through touching the affected skin of someone who has the infection, touching sheets or clothes that has been used by someone with the infection, or breathing in particles of virus from someone who has the infection. Mpox infection can cause skin and flu-like symptoms, but can also cause very few symptoms, or no symptoms at all. While the number of participants with mpox symptoms can be tracked, little is known about how many people have mpox, but experience few or no symptoms at all. To do this, a Canadian sample of gay, bisexual and other men who have sex with men (GBMSM) who are participating in a randomized controlled trial will be screened for mpox symptoms. Screening will include questions about whether they may be experiencing any mpox symptoms, history of past diagnosis of mpox, sexual history, and vaccination history and awareness. Swabs will be taken to test for the presence of mpox virus, and a blood sample will be taken to test for antibodies. Approximately 450 individuals will be recruited. The results will be descriptive in nature.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Respiratory Outbreak Mitigation in Long-Term Care Using Point-of-Care Testing

NCT06660433

Outbreaks
RECRUITING NA

Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens

NCT04431050

Human Influenza Respiratory Syncytial Virus Infections Rhinoviral Infections +3 more
TERMINATED

PCOT for Outpatients With Acute Respiratory Tract Infection at Risk of Severe Disease in Primary Healthcare

NCT07159230

Acute Respiratory Tract Infection
NOT_YET_RECRUITING NA

Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic

NCT06349707

Viral Pneumonia
COMPLETED

SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings

NCT06191393

SARS-CoV-2 Infection Influenza A Influenza B
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mpox (Monkeypox)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Participants need to have been enrolled in an existing randomized clinical trial (NCT04762134)

Exclusion Criteria

\- None
Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Unity Health Toronto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Unity Health Toronto

Toronto, Ontario, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Abby Li, MSc

Role: CONTACT

[email protected]
416-360-4000 ext. 77426

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Reva Persaud

Role: primary

[email protected]
416-360-4000 ext. 77105

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CTO 4489

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples
NCT01597089 TERMINATED
Detection of Bacterial and Viral Pathogens Infection Among Hospitalized Patients Feasibility Study
NCT05399615 WITHDRAWN NA
Testing for COVID-19 Infection in Asymptomatic Persons
NCT04345510 COMPLETED
Infectious Pathogens in Acute Respiratory Illness in Adults and Elderly
NCT01360398 COMPLETED NA
Detection of Asymptomatic SARS-Cov2 Infected Patients by Detection Dogs: "Proof of Concept" Study (CoviDetectionDog)-Covid-19
NCT04970563 COMPLETED NA
A Study to Determine the Epidemiology and Evaluate the Burden of Disease in Respiratory Syncytial Virus/Human Metapneumovirus and Influenza A Infected Hospitalized Participants (Adults and Children)
NCT03574532 COMPLETED
Pilot Test of COVID-19 Related Clinical Outcome Assessment Methodology and Qualitative Evidence of Content Validity
NCT05207293 COMPLETED
Point of Care Polymerase Chain Reaction (PCR) Diagnostics of Respiratory Tract Infections in General Practice
NCT06120153 ACTIVE_NOT_RECRUITING NA
A Long-term Observational Study Evaluating the Presentation and Management of Acute Respiratory Tract Infections in Primary Care Across Europe
NCT06282718 RECRUITING
Development and Validation of an Early Prediction Model for Severe Mycoplasma Pneumoniae Pneumonia in Children
NCT07333833 COMPLETED
Volatile Organic Compounds Analysis by PTR-TOF-MS for Screening Respiratory Infections Using Exhaled Breath.
NCT07348380 NOT_YET_RECRUITING NA
Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control
NCT06286007 RECRUITING
COVID-19 Novel Molecular Point of Care Diagnostics Evaluation
NCT06055218 COMPLETED
Tocilizumab in Covid-19 Penumonia in Buenos Aires City
NCT05057962 COMPLETED
Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013
NCT01747369 UNKNOWN
Clinical Decision Rules in the Emergency Department to Improve the Management of Acute Respiratory Infection and Acute Infectious Diarrhea
NCT05322694 COMPLETED
Screening for COVID-19
NCT04615208 WITHDRAWN
Virus Interactions in the Respiratory Tract; a Cohort Study With Children
NCT05318235 COMPLETED
Routine Application of Point-of-care PCR Test to Identify and Direct Therapy for Acute Respiratory Infection in the Emergency Department Trial
NCT06780566 NOT_YET_RECRUITING NA
Nasal Specimen Collection Study in Patients With ILI and/or ARI in an Outpatient Setting
NCT01687816 UNKNOWN
Febrile Whole Blood Specimen Collection and Testing
NCT03498027 COMPLETED
Point of Care Testing Using FebriDx in Primary Care: a Mixed Methods Feasibility Study
NCT05534555 UNKNOWN NA
Oxygen Requirements and Use in Patients With COVID-19 in LMICs
NCT04918875 UNKNOWN
Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy
NCT00001477 COMPLETED
M-ROSE Combined With mNGS in Severe Hospital-acquired Pneumonia
NCT05300776 UNKNOWN NA